Advanced search
Publication Cover
Cancer Biology & Therapy Volume 14, 2013 - Issue 2
Submit an article Journal homepage
658
Views
2
CrossRef citations to date
0
Altmetric
Brief Communication

A molecular case report

Functional assay of tyrosine kinase inhibitors in cells from a patient’s primary renal cell carcinoma

Molly Kulesz-Martin Knight Cancer Institute and Department of Dermatology; Oregon Health and Science University; Portland, OR USACorrespondence[email protected] [email protected]
,
James Lagowski Knight Cancer Institute and Department of Dermatology; Oregon Health and Science University; Portland, OR USA
,
Susan Olson Knight Cancer Institute and Department of Molecular and Medical Genetics; Oregon Health and Science University; Portland, OR USA
,
Aaron Wortham Knight Cancer Institute and Department of Dermatology; Oregon Health and Science University; Portland, OR USA
,
Toni West Knight Cancer Institute and Department of Dermatology; Oregon Health and Science University; Portland, OR USA
,
George Thomas Knight Cancer Institute and Department of Pathology; Oregon Health and Science University; Portland, OR USA
,
Christopher W. Ryan Knight Cancer Institute and Division of Hematology/Oncology; Oregon Health and Science University; Portland, OR USACorrespondence[email protected] [email protected]
&
Jeffrey W. Tyner Knight Cancer Institute and Department of Cell and Developmental Biology; Oregon Health and Science University; Portland, OR USA
 show all
Pages 95-99 | Received 09 Nov 2012, Accepted 18 Nov 2012, Published online: 28 Nov 2012

References

  • Druker BJ, Talpaz M, Resta DJ, Peng B, Buchdunger E, Ford JM, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001; 344:1031 - 7; http://dx.doi.org/10.1056/NEJM200104053441401; PMID: 11287972
  • Tyner JW, Erickson H, Deininger MW, Willis SG, Eide CA, Levine RL, et al. High-throughput sequencing screen reveals novel, transforming RAS mutations in myeloid leukemia patients. Blood 2009; 113:1749 - 55; http://dx.doi.org/10.1182/blood-2008-04-152157; PMID: 19075190
  • Tyner JW, Fletcher LB, Wang EQ, Yang WF, Rutenberg-Schoenberg ML, Beadling C, et al. MET receptor sequence variants R970C and T992I lack transforming capacity. Cancer Res 2010; 70:6233 - 7; http://dx.doi.org/10.1158/0008-5472.CAN-10-0429; PMID: 20670955
  • Tyner JW, Yang WF, Bankhead A, Fan G, Fletcher LB, Bryant J, et al. Kinase Pathway Dependence in Primary Human Leukemias Determined by Rapid Inhibitor Screening. Cancer Res 2012; http://dx.doi.org/10.1158/0008-5472.CAN-12-1906; PMID: 23087056
  • Suwaki N, Vanhecke E, Atkins KM, Graf M, Swabey K, Huang P, et al. A HIF-regulated VHL-PTP1B-Src signaling axis identifies a therapeutic target in renal cell carcinoma. Sci Transl Med 2011; 3:85ra47; http://dx.doi.org/10.1126/scitranslmed.3002004; PMID: 21632985
  • Sternberg CN, Davis ID, Mardiak J, Szczylik C, Lee E, Wagstaff J, et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol 2010; 28:1061 - 8; http://dx.doi.org/10.1200/JCO.2009.23.9764; PMID: 20100962
  • Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, Lau KW, et al. Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 2012; 483:570 - 5; http://dx.doi.org/10.1038/nature11005; PMID: 22460902
  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144:646 - 74; http://dx.doi.org/10.1016/j.cell.2011.02.013; PMID: 21376230
  • Hanahan D, Coussens LM. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21:309 - 22; http://dx.doi.org/10.1016/j.ccr.2012.02.022; PMID: 22439926
  • Jaganathan S, Yue P, Paladino DC, Bogdanovic J, Huo Q, Turkson J. A functional nuclear epidermal growth factor receptor, SRC and Stat3 heteromeric complex in pancreatic cancer cells. PLoS One 2011; 6:e19605; http://dx.doi.org/10.1371/journal.pone.0019605; PMID: 21573184
  • Dancey JE. Epidermal growth factor receptor and epidermal growth factor receptor therapies in renal cell carcinoma: do we need a better mouse trap?. J Clin Oncol 2004; 22:2975 - 7; http://dx.doi.org/10.1200/JCO.2004.04.934; PMID: 15210735
  • An J, Rettig MB. Epidermal growth factor receptor inhibition sensitizes renal cell carcinoma cells to the cytotoxic effects of bortezomib. Mol Cancer Ther 2007; 6:61 - 9; http://dx.doi.org/10.1158/1535-7163.MCT-06-0255; PMID: 17237266
  • Akbulut T, Regner KR, Roman RJ, Avner ED, Falck JR, Park F. 20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism. Am J Physiol Renal Physiol 2009; 297:F662 - 70; http://dx.doi.org/10.1152/ajprenal.00146.2009; PMID: 19570883
  • Suzuki T, Fujii A, Ochi H, Nakamura H. Ubiquitination and downregulation of ErbB2 and estrogen receptor-alpha by kinase inhibitor MP-412 in human breast cancer cells. J Cell Biochem 2011; 112:2279 - 86; http://dx.doi.org/10.1002/jcb.23147; PMID: 21503962
  • Kulesz-Martin MF, McLimans WF. Steady-state cultures of human skin. Exp Cell Biol 1982; 50:195 - 206; PMID: 6749572
  • Rheinwald JG, Jorgensen JL, Hahn WC, Terpstra AJ, O’Connell TM, Plummer KK. Mesosecrin: a secreted glycoprotein produced in abundance by human mesothelial, endothelial, and kidney epithelial cells in culture. J Cell Biol 1987; 104:263 - 75; http://dx.doi.org/10.1083/jcb.104.2.263; PMID: 3543023
  • Rheinwald JG, O’Connell TM. Intermediate filament proteins as distinguishing markers of cell type and differentiated state in cultured human urinary tract epithelia. Ann N Y Acad Sci 1985; 455:259 - 67; http://dx.doi.org/10.1111/j.1749-6632.1985.tb50416.x; PMID: 3866508
  • Casalone R, Granata Casalone P, Minelli E, Portentoso P, Righi R, Meroni E, et al. Significance of the clonal and sporadic chromosome abnormalities in non-neoplastic renal tissue. Hum Genet 1992; 90:71 - 8; http://dx.doi.org/10.1007/BF00210747; PMID: 1427791
  • van den Berg E, van der Hout AH, Oosterhuis JW, Störkel S, Dijkhuizen T, Dam A, et al. Cytogenetic analysis of epithelial renal-cell tumors: relationship with a new histopathological classification. Int J Cancer 1993; 55:223 - 7; http://dx.doi.org/10.1002/ijc.2910550210; PMID: 8370620

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.